Every Form 4 that BioVie Inc. Warrant (BIVIW) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow BIVIW and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full BIVIW filings page.
BIOVIE INC. (BIVI) reported that Chief Medical Officer Joseph M. Palumbo purchased common stock. On 2026-08-28 he bought 4,843 shares of common stock in open market transactions at $2.16 per share, bringing his directly held position to 6,036 shares.
The shares were acquired in several open market trades, all executed at the same price.
BIOVIE INC. (BIVI) director Amy Suzon Chappell purchased 727 shares of Common Stock on 2026-08-28 in an open market transaction at $2.16 per share. Following this reported transaction, she directly owns 727 shares of BIOVIE INC. common stock.
BIOVIE INC. (BIVI) reported that its Chief Financial Officer, Joanne Wendy Kim, purchased 2,500 shares of common stock in an open market transaction on 2026-08-28 at a price of $2.18 per share. Following this purchase, she directly holds 3,441 shares of BIOVIE INC. common stock.
BIOVIE INC. (BIVI) reported that President & CEO Cuong V. Do purchased common stock on August 27, 2026. He bought 15,210 shares of BioVie common stock in open market transactions at a weighted average price of $2.08 per share, with trade prices ranging from $2.05 to $2.10. Following this purchase, he directly holds 16,117 common shares of BioVie.